Jean Bergeron

4.3k total citations
80 papers, 2.9k citations indexed

About

Jean Bergeron is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jean Bergeron has authored 80 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 33 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jean Bergeron's work include Lipoproteins and Cardiovascular Health (47 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers) and Lipid metabolism and disorders (17 papers). Jean Bergeron is often cited by papers focused on Lipoproteins and Cardiovascular Health (47 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers) and Lipid metabolism and disorders (17 papers). Jean Bergeron collaborates with scholars based in Canada, United States and Italy. Jean Bergeron's co-authors include Patrick Couture, Benoı̂t Lamarche, Claude Gagné, André Tremblay, Nathalie Bergeron, Charles Couillard, Robert A. Hegele, Jean‐Charles Hogue, Jacques Genest and Jean‐Pierre Després and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Jean Bergeron

78 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean Bergeron Canada	29	1.3k	989	620	512	479	80	2.9k
John H. Contois United States	28	1.6k 1.2×	1.6k 1.6×	686 1.1×	405 0.8×	535 1.1×	49	3.5k
Núria Plana Spain	29	1.4k 1.1×	859 0.9×	689 1.1×	726 1.4×	278 0.6×	161	2.9k
Ulrich Julius Germany	28	1.5k 1.1×	1.5k 1.5×	735 1.2×	548 1.1×	448 0.9×	173	3.6k
Michael S. Kostapanos Greece	25	1.1k 0.8×	801 0.8×	491 0.8×	352 0.7×	257 0.5×	79	2.5k
Juan F. Ascaso Spain	25	945 0.7×	1.1k 1.1×	446 0.7×	392 0.8×	423 0.9×	147	2.6k
Teik Chye Ooi Canada	27	1.2k 0.9×	1.0k 1.0×	633 1.0×	361 0.7×	323 0.7×	79	2.4k
Shari Wang United States	21	1.3k 1.0×	1.0k 1.0×	428 0.7×	673 1.3×	434 0.9×	35	2.9k
Davide Noto Italy	30	1.2k 0.9×	947 1.0×	839 1.4×	496 1.0×	349 0.7×	135	2.9k
Kjetil Retterstøl Norway	33	1.6k 1.3×	946 1.0×	593 1.0×	520 1.0×	742 1.5×	189	3.7k
Kathleen Wyne United States	21	986 0.8×	994 1.0×	460 0.7×	565 1.1×	364 0.8×	64	2.5k

Countries citing papers authored by Jean Bergeron

Since Specialization

Citations

This map shows the geographic impact of Jean Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Bergeron more than expected).

Fields of papers citing papers by Jean Bergeron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Bergeron. The network helps show where Jean Bergeron may publish in the future.

Co-authorship network of co-authors of Jean Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Bergeron. A scholar is included among the top collaborators of Jean Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Bergeron. Jean Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kessler, Asia Sikora, T. Michelle Brown, Emily Bratlee‐Whitaker, et al.. (2025). Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants. Journal of clinical lipidology. 19(5). 1243–1255. 1 indexed citations

Alexander, Veronica J., Marcello Arca, Jean Bergeron, et al.. (2025). Prevalence, baseline characteristics, and reclassification of indeterminate genetic results in patients eligible for the Balance trial with olezarsen. Journal of clinical lipidology. 19(3). e72–e72. 1 indexed citations

Brown, Leslie, Isabelle L. Ruel, Alexis Baass, et al.. (2024). Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia. Journal of clinical lipidology. 18(2). e189–e196. 3 indexed citations

Ruel, Isabelle L., Patrick Couture, Jean Bergeron, et al.. (2023). Familial hypercholesterolemia in Canada: Investigating management patterns and clinical outcomes from the FH Canada registry. Atherosclerosis. 379. S31–S31. 1 indexed citations

Raal, Frederick J., Jean Bergeron, Gerald F. Watts, et al.. (2023). ARO-ANG3, an investigational RNAI therapeutic, decreases serum LDL-cholesterol, apolipoprotein B, and angiopoietin-like protein 3 in patients with homozygous familial hypercholesterolaemia. Atherosclerosis. 379. S43–S44. 6 indexed citations

Brown, Leslie, Isabelle L. Ruel, Alexis Baass, et al.. (2023). Homozygous Familial Hypercholesterolemia in Canada. JACC Advances. 2(3). 100309–100309. 5 indexed citations

Santos, Raúl D., Andrea Ruzza, G. Kees Hovingh, et al.. (2020). Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. New England Journal of Medicine. 383(14). 1317–1327. 115 indexed citations

Drouin‐Chartier, Jean‐Philippe, André Tremblay, Jean Bergeron, Benoı̂t Lamarche, & Patrick Couture. (2018). High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption. Atherosclerosis. 270. 26–32. 1 indexed citations

Maltais, Alexandre, Natalie Alméras, Isabelle Lemieux, et al.. (2018). Trunk muscle quality assessed by computed tomography: Association with adiposity indices and glucose tolerance in men. Metabolism. 85. 205–212. 41 indexed citations

10.

Genest, Jacques, Robert A. Hegele, Jean Bergeron, et al.. (2014). Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia. Canadian Journal of Cardiology. 30(12). 1471–1481. 74 indexed citations

11.

Campeau, Philippe M., Olga Astapova, Jean Bergeron, et al.. (2012). Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency. Journal of Lipid Research. 53(9). 1968–1978. 18 indexed citations

12.

Décary, Simon, Benoı̂t Lamarche, Jean‐Charles Hogue, et al.. (2009). Assessment of the validity of the frequently used lipid indices for predicting LDL peak particle diameter in a large cohort of 1955 normal and dyslipidemic subjects. Clinical Biochemistry. 43(4-5). 401–406. 11 indexed citations

13.

Hogue, Jean‐Charles, Benoı̂t Lamarche, André Tremblay, et al.. (2007). Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. Journal of Lipid Research. 48(6). 1336–1342. 100 indexed citations

14.

Sniderman, Allan D., André Tremblay, Jean Bergeron, Claude Gagné, & Patrick Couture. (2007). Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B. Journal of clinical lipidology. 1(4). 256–263. 51 indexed citations

15.

Couillard, Charles, Sonia Pomerleau, Guillaume Ruel, et al.. (2006). Associations between hypertriglyceridemia, dietary fat intake, oxidative stress, and endothelial activation in men. Nutrition. 22(6). 600–608. 14 indexed citations

16.

Archer, W. Roodly, Sophie Desroches, Benoı̂t Lamarche, et al.. (2005). Variations in plasma apolipoprotein C-III levels are strong correlates of the triglyceride response to a high-monounsaturated fatty acid diet and a high-carbohydrate diet. Metabolism. 54(10). 1390–1397. 15 indexed citations

17.

Desroches, Sophie, Marie‐Ève Paradis, W. Roodly Archer, et al.. (2004). Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men. Journal of Lipid Research. 45(12). 2331–2338. 27 indexed citations

18.

Archer, W. Roodly, Annie St‐Pierre, Jean‐François Mauger, et al.. (2003). High Carbohydrate and High Monounsaturated Fatty Acid Diets Similarly Affect LDL Electrophoretic Characteristics in Men Who Are Losing Weight. Journal of Nutrition. 133(10). 3124–3129. 21 indexed citations

19.

Dumont, Martine, Pascale Mauriège, Jean Bergeron, JP Després, & Denis Prud’homme. (2001). Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men. International Journal of Obesity. 25(8). 1136–1143. 15 indexed citations

20.

Couillard, Charles, Nathalie Bergeron, Jean Bergeron, et al.. (2000). Metabolic Heterogeneity Underlying Postprandial Lipemia among Men with Low Fasting High Density Lipoprotein Cholesterol Concentrations¹. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4575–4582. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact